Akebia Therapeutics Stock Forecast

Buy or Hold candidate since Jun 22, 2026 Gain 4.59%

The Akebia Therapeutics stock price gained 2.70% on the last trading day (Tuesday, 30th Jun 2026), rising from $1.11 to $1.14. During the last trading day the stock fluctuated 16.22% from a day low at $1.11 to a day high of $1.29. The price has risen in 7 of the last 10 days and is up by 21.44% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 million more shares were traded than the day before. In total, 7 million shares were bought and sold for approximately $7.78 million.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $1.12, a level that may pose a second chance to hit a runner. According to fan-theory $1.49 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

AKBA Signals & Forecast

The Akebia Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.10 and $1.02. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 26, 2026, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Akebia Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.07 and $1.02. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Akebia Therapeutics finds support just below today's level at $1.07. If this is broken, then the next support from accumulated volume will be at $1.02 and $1.01.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.180 between high and low, or 16.22%. For the last week, the stock has had daily average volatility of 9.16%.

Our recommended stop-loss: $1.10 (-3.56%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (AKBA) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Akebia Therapeutics to open at $1.18, and during the day (based on 14 day Average True Range), to move between $1.10 and $1.18, which gives a possible trading interval of +/-$0.0824 (+/-7.49%) up or down from last closing price. If Akebia Therapeutics takes out the full calculated possible swing range there will be an estimated 7.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.18 (3.51%) than the support at $1.07 (6.14%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Akebia Therapeutics stock A Buy?

Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.380 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 1, 2026 - $1.18 ( 3.51%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk